In our recent News and Views, T. Jake Liang from NIDDKgov discusses new strategies based on nucleic acid technologies to treat chronic hepatitis B WorldHepatitisDay
Chronic infection with hepatitis B virus afflicts more than 250 million people worldwide.
Effective vaccines and treatments that potently suppress viral levels and reduce liver inflammation have been available for over 20 years, but infection with HBV continues to exact a heavy public-health toll. The goal of a ‘cure’ for chronic infection with HBV remains elusive. At present, nucleoside analogs and interferon-α are the only approved therapies, and they rarely cure the infection
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
A blueprint for eliminating cholera by 2030 - Nature MedicineCholera is endemic in 47 countries, but deaths from this disease can be eliminated with a package of low-cost measures implemented by community healthcare workers.
Baca lebih lajut »
Financing the health needs of Ukrainian refugees - Nature MedicineFinancing the health needs of Ukrainian refugees. Correspondence from Wu Zeng Georgetown.
Baca lebih lajut »
Symptoms and risk factors for long COVID in non-hospitalized adults - Nature MedicineA retrospective analysis of primary care records in the UK reveals individual symptoms associated with SARS-CoV-2 infections that persisted for 12 weeks or more post-infection, as well as risk factors associated with developing LongCOVID unibirmingham
Baca lebih lajut »
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial - Nature MedicineA first-in-human study of an antisense oligonucleotide targeting hepatitis B virus RNA provides initial insights into this potential new therapeutic modality for individuals with chronic HBV infection ASO HKUniversity NMEDClinical WorldHepatitisDay
Baca lebih lajut »
Global elimination of hepatitis C virus by 2030: why not? - Nature MedicineThe World Health Organization’s targets for eliminating hepatitis C virus by 2030 have been deemed ambitious by many. However, we believe they are achievable, provided they are supported by global commitment.
Baca lebih lajut »
Genetic risk score enhances the risk prediction of severe obesity in adult survivors of childhood cancer - Nature MedicineA report from large cohorts of adult survivors of childhood cancer demonstrates that polygenic scores improve the risk prediction of developing severe obesity, providing opportunities for surveillance and mitigation interventions YadavSapkota8 StJude
Baca lebih lajut »